DK1504266T3 - Fremgangsmåde til samtidig detektering af en infekteret mikroorganismes antigen og antistof - Google Patents
Fremgangsmåde til samtidig detektering af en infekteret mikroorganismes antigen og antistofInfo
- Publication number
- DK1504266T3 DK1504266T3 DK03749938.1T DK03749938T DK1504266T3 DK 1504266 T3 DK1504266 T3 DK 1504266T3 DK 03749938 T DK03749938 T DK 03749938T DK 1504266 T3 DK1504266 T3 DK 1504266T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- antibody
- simultaneously detecting
- infected microorganism
- infected
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
- C07K14/1833—Hepatitis C; Hepatitis NANB
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
- C07K14/161—HIV-1 ; HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0205808A FR2839555B1 (fr) | 2002-05-10 | 2002-05-10 | Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux |
PCT/FR2003/001429 WO2003095968A2 (fr) | 2002-05-10 | 2003-05-09 | Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1504266T3 true DK1504266T3 (da) | 2013-11-11 |
Family
ID=29286402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03749938.1T DK1504266T3 (da) | 2002-05-10 | 2003-05-09 | Fremgangsmåde til samtidig detektering af en infekteret mikroorganismes antigen og antistof |
Country Status (13)
Country | Link |
---|---|
US (4) | US7364860B2 (da) |
EP (1) | EP1504266B1 (da) |
JP (1) | JP4351153B2 (da) |
CN (2) | CN100592086C (da) |
AU (1) | AU2003254529B2 (da) |
CA (2) | CA2775017C (da) |
DK (1) | DK1504266T3 (da) |
ES (1) | ES2433920T3 (da) |
FR (1) | FR2839555B1 (da) |
PT (1) | PT1504266E (da) |
RU (1) | RU2300769C2 (da) |
WO (1) | WO2003095968A2 (da) |
ZA (1) | ZA200408979B (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4533656B2 (ja) * | 2004-04-28 | 2010-09-01 | アボットジャパン株式会社 | 特異性の改良されたc型肝炎ウイルス(hcv)抗体測定法 |
CN101704583A (zh) * | 2004-05-24 | 2010-05-12 | 方太海德有限公司 | 浮岛 |
KR101035111B1 (ko) * | 2004-06-30 | 2011-05-19 | 주식회사 엘지생명과학 | 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단 |
JP2006071631A (ja) * | 2004-08-06 | 2006-03-16 | Bl:Kk | フラビウイルス科ペスチウイルス属ウイルスの検出法およびそのイムノクロマトグラフィーにおける使用 |
FR2874017B1 (fr) * | 2004-08-06 | 2006-11-24 | Bio Rad Pasteur Sa | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih |
ATE441114T1 (de) * | 2005-12-14 | 2009-09-15 | Jordanian Pharmaceutical Mfg | Vorrichtung zum frühen und schnellen immunochromatographischen nachweis von hiv und dessen anwendung |
US8865398B2 (en) * | 2006-09-01 | 2014-10-21 | Abbott Laboratories | Combination hepatitis C virus antigen and antibody detection method |
JP2008145181A (ja) * | 2006-12-07 | 2008-06-26 | Abbott Japan Co Ltd | パルボウイルスb19の検出法 |
EP1933148B1 (en) * | 2006-12-11 | 2010-08-25 | AraGen Biotechnology Co. Ltd. | Urinary immunochromatographic multiparameter detection cup |
FR2917173B1 (fr) * | 2007-06-08 | 2009-07-31 | Bio Rad Pasteur Sa | Procede multiplexe de detection d'une infection |
CN102378914B (zh) * | 2009-03-30 | 2014-12-10 | 生物梅里埃公司 | 用于hcv检测的固体支持物 |
US8518658B1 (en) * | 2009-04-27 | 2013-08-27 | University Of South Florida | ATP-bioluminescence immunoassay |
US20100297607A1 (en) | 2009-05-20 | 2010-11-25 | Jian Zheng | Reagents For HCV Antigen-Antibody Combination Assays |
FR2984328B1 (fr) * | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
RU2488832C1 (ru) * | 2012-01-13 | 2013-07-27 | Общество с ограниченной ответственностью "Передовые диагностические платформы" | Способ комплексной диагностики инфекционных заболеваний человека путем твердофазного иммуноферментного анализа |
CN105228649B (zh) | 2013-03-14 | 2019-01-18 | 雅培制药有限公司 | Hcv抗原-抗体组合测定和方法以及用在其中的组合物 |
US9371374B2 (en) | 2013-03-14 | 2016-06-21 | Abbott Laboratories | HCV core lipid binding domain monoclonal antibodies |
MX2015012824A (es) | 2013-03-14 | 2016-06-24 | Abbott Lab | Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos. |
JP6808178B2 (ja) * | 2015-10-15 | 2021-01-06 | 富士レビオ株式会社 | ヒトパルボウイルスb19抗原および抗体の同時検出方法及びキット |
CN106119208B (zh) * | 2016-04-28 | 2019-04-16 | 北京市肝病研究所 | Hcv ns3单克隆抗体及丙型肝炎检测试剂盒 |
CN109725153B (zh) * | 2017-10-26 | 2022-05-13 | 科美诊断技术股份有限公司 | 一种均相免疫检测方法及其应用 |
FR3110245A1 (fr) * | 2019-05-16 | 2021-11-19 | Universite Jean Monnet Saint Etienne | Procede de detection de pneumocoques |
CN112816700A (zh) * | 2020-12-28 | 2021-05-18 | 杭州新脉生物科技有限公司 | 一种检测尿液中hiv抗体的胶体金试纸条 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA855031B (en) * | 1984-08-31 | 1986-02-26 | New York Blood Center Inc | Assay for simultaneous detection of antigen and antibody in given serum |
US4870003A (en) * | 1987-06-15 | 1989-09-26 | Coulter Corporation | Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans |
CA1335880C (en) * | 1988-07-14 | 1995-06-13 | Thomas P. O'connor | Detection of an antibody and antigen in an immunoassay |
US5191064A (en) * | 1988-09-30 | 1993-03-02 | The Research Foundation For Microbial Diseases (Osaka University) | Non-a, non-b hepatitis virus antigen peptide |
HUT54896A (en) * | 1989-03-17 | 1991-04-29 | Chiron Corp | Process for producing aquous diagnosticum and vaccine of nanbv |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
ZA912040B (en) * | 1990-03-30 | 1991-12-24 | Akzo Nv | Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus |
WO1992022571A1 (en) * | 1991-06-13 | 1992-12-23 | Baxter Diagnostics Inc. | Immunoassay for non-a non-b hepatitis |
NZ243636A (en) * | 1991-07-29 | 1993-06-25 | Iaf Biochem Int | Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11 |
JP2001504572A (ja) * | 1992-04-09 | 2001-04-03 | アボツト・ラボラトリーズ | Hiv抗原及びhiv抗体を検出するためのアッセイ |
EP0698214A1 (en) * | 1994-03-02 | 1996-02-28 | Abbott Laboratories | Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents |
US5591847A (en) | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
JPH10502165A (ja) * | 1994-05-31 | 1998-02-24 | アボツト・ラボラトリーズ | 合成ペプチド−改良イムノアッセイを使用する異なるhiv遺伝子型の検出 |
GB2313666A (en) * | 1996-05-28 | 1997-12-03 | Hoffmann La Roche | Assay for detecting HIV antigens and HIV antibodies |
JP3534417B2 (ja) * | 1997-03-10 | 2004-06-07 | ロシュ ダイアグノスティックス ゲーエムベーハー | Hiv抗原及びhiv抗体の同時決定方法 |
DE19720914A1 (de) * | 1997-05-16 | 1998-11-19 | Boehringer Mannheim Gmbh | Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene |
AU2790899A (en) * | 1998-03-04 | 1999-09-20 | Universal Health-Watch, Inc. | Rapid confirmatory test for microbial infections |
US6623921B2 (en) * | 1998-07-30 | 2003-09-23 | Advanced Life Science Institute, Inc. | Method for measurement of hepatitis C virus |
AU774887B2 (en) * | 1999-07-09 | 2004-07-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
JP3536731B2 (ja) * | 1999-07-28 | 2004-06-14 | 富士レビオ株式会社 | HIV−1p24抗原の免疫測定方法及び試薬 |
US6383740B2 (en) * | 1999-07-30 | 2002-05-07 | Bioergonomics, Inc. | Methods for simultaneously detecting both members of a binding pair |
US6762032B1 (en) * | 1999-08-23 | 2004-07-13 | Biocrystal, Ltd. | Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
AU2001272945A1 (en) * | 2000-06-15 | 2001-12-24 | Chiron Corporation | Immunoassays for anti-hcv antibodies |
EP1412538B1 (en) * | 2001-06-26 | 2013-03-27 | Abbott Laboratories | Methods for the simultaneous detection of hcv antigens and hcv antibodies |
-
2002
- 2002-05-10 FR FR0205808A patent/FR2839555B1/fr not_active Expired - Lifetime
-
2003
- 2003-05-08 US US10/431,587 patent/US7364860B2/en active Active
- 2003-05-09 DK DK03749938.1T patent/DK1504266T3/da active
- 2003-05-09 AU AU2003254529A patent/AU2003254529B2/en not_active Expired
- 2003-05-09 JP JP2004503914A patent/JP4351153B2/ja not_active Expired - Lifetime
- 2003-05-09 CN CN03813516A patent/CN100592086C/zh not_active Expired - Lifetime
- 2003-05-09 PT PT37499381T patent/PT1504266E/pt unknown
- 2003-05-09 CN CN2010101041551A patent/CN101858911B/zh not_active Expired - Lifetime
- 2003-05-09 EP EP03749938.1A patent/EP1504266B1/fr not_active Revoked
- 2003-05-09 ES ES03749938T patent/ES2433920T3/es not_active Expired - Lifetime
- 2003-05-09 WO PCT/FR2003/001429 patent/WO2003095968A2/fr active Application Filing
- 2003-05-09 RU RU2004136165/15A patent/RU2300769C2/ru active
- 2003-05-09 CA CA2775017A patent/CA2775017C/fr not_active Expired - Lifetime
- 2003-05-09 CA CA2483945A patent/CA2483945C/fr not_active Expired - Lifetime
-
2004
- 2004-11-05 ZA ZA200408979A patent/ZA200408979B/en unknown
-
2008
- 2008-03-13 US US12/076,090 patent/US8168394B2/en not_active Expired - Fee Related
-
2012
- 2012-03-30 US US13/435,381 patent/US8729234B2/en not_active Expired - Lifetime
- 2012-03-30 US US13/435,325 patent/US8728723B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4351153B2 (ja) | 2009-10-28 |
CN100592086C (zh) | 2010-02-24 |
US8168394B2 (en) | 2012-05-01 |
CA2775017C (fr) | 2017-06-06 |
CA2483945A1 (fr) | 2003-11-20 |
WO2003095968A3 (fr) | 2004-03-25 |
AU2003254529A1 (en) | 2003-11-11 |
CN101858911A (zh) | 2010-10-13 |
US8728723B2 (en) | 2014-05-20 |
FR2839555A1 (fr) | 2003-11-14 |
CA2483945C (fr) | 2012-09-04 |
JP2006501151A (ja) | 2006-01-12 |
US20080241855A1 (en) | 2008-10-02 |
WO2003095968A2 (fr) | 2003-11-20 |
CN101858911B (zh) | 2013-01-02 |
EP1504266B1 (fr) | 2013-08-07 |
RU2004136165A (ru) | 2005-10-27 |
EP1504266A2 (fr) | 2005-02-09 |
ES2433920T3 (es) | 2013-12-13 |
US20040072267A1 (en) | 2004-04-15 |
FR2839555B1 (fr) | 2007-07-27 |
RU2300769C2 (ru) | 2007-06-10 |
CN1659440A (zh) | 2005-08-24 |
PT1504266E (pt) | 2013-11-11 |
US20130158233A1 (en) | 2013-06-20 |
ZA200408979B (en) | 2006-08-30 |
US20130157255A1 (en) | 2013-06-20 |
US8729234B2 (en) | 2014-05-20 |
US7364860B2 (en) | 2008-04-29 |
CA2775017A1 (fr) | 2003-11-20 |
AU2003254529B2 (en) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1504266T3 (da) | Fremgangsmåde til samtidig detektering af en infekteret mikroorganismes antigen og antistof | |
DK1406656T3 (da) | Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer | |
DK1293574T3 (da) | Reagenser, fremgangsmåder og indretninger til bestemmelse af analytter | |
NO20044347L (no) | Anti-alfavbeta6-antistoff | |
NO20034937D0 (no) | Anordning og fremgangsmåte for forsegling av rör-mellomstykke | |
DK1576132T3 (da) | Nukleinsyrer benævnt 273p4b7 og anvendelse heraf til detektering af cancer | |
DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
ATE555809T1 (de) | Pharmezeutische anti-tnf-alpha antikörper formulierung | |
DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
ITBO20020531A1 (it) | Dispositivo e metodo di giunzione di nastri. | |
DK1532569T3 (da) | Fremgangsmåde og indretning til kodning af genstande | |
DE60302420D1 (de) | Musiksuchgerät und -verfahren | |
DK1510492T3 (da) | Fremgangsmåde til afprövning af et elevatoranlæg og elevatoranlæg | |
ITVA20020060A0 (it) | Metodo di analisi di immagini rilevate da un micro-array e relativo dispositivo | |
NO20053079D0 (no) | System og fremgangsmate for riggtilstands-detektering. | |
DK1426784T3 (da) | Indretning og fremgangsmåde til positionsbestemmelse | |
DE60319191D1 (de) | Brückenvorrichtung und -verfahren | |
DK1337547T3 (da) | Nuklease-baseret fremgangsmåde til detektion og kvantificering af oligonukleotider | |
DK1482311T3 (da) | Indretning og fremgangsmåde til bestemmelse af et projektils mundingshastighed | |
NO20030805D0 (no) | Fremgangsmåte for gassdeteksjon gjennom kapsling | |
DK1310763T3 (da) | Fremgangsmåde og indretning til detektering af installeringspositionen for en krumtapaksel, og program til detektering af denne installeringsposition | |
NO20043505L (no) | Rorelement, samt anordning og fremgangsmate for tilvirkning | |
IS7486A (is) | Næm aðferð til að greina kjarnsýrur | |
DK1386160T3 (da) | Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse | |
FI20020584A (fi) | Menetelmä havainnointialueen mittakaavan määrittämiseksi |